New Data, New Perspectives in Ovarian Cancer: Experts Discuss the Current Paradigm and Long-term Benefits of PARP Inhibitor Therapy

Download All
Gain a deeper understanding of how PARP inhibitors fit into current treatment approaches in ovarian cancer in this on-demand webcast and audio podcast, then download the slides for use in your own presentations.
Nicoletta Colombo, MD
person default
Philipp Harter, MD, PhD
person default
Alexandra Leary, MD, PhD

On-Demand Webcast

Watch this on-demand webcast capturing a live CCO webinar during IGCS 2021 of experts discussing the evolving strategies and expanding role of PARP inhibitors in managing patients with ovarian cancer.

Nicoletta Colombo, MD person default Philipp Harter, MD, PhD person default Alexandra Leary, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: October 4, 2021 Expired: October 3, 2022

Downloadable Slidesets

Download this slideset on the current advances and evolving landscape of PARP inhibitors for patients with ovarian cancer.

Nicoletta Colombo, MD Released: September 3, 2021

Download this slideset discussing a clinical case of PARP inhibitors for a patient with ovarian cancer.

person default Philipp Harter, MD, PhD Released: September 3, 2021

Download this slideset on maintenance strategies for newly diagnosed patients with BRCA1/2-mutated ovarian cancer.

person default Alexandra Leary, MD, PhD Released: September 3, 2021

Download this short summary slideset of key takeaway points from a live presentation on the global perspectives on the current paradigm and long term benefits of PARPi in the treatment of ovarian cancer. 

Nicoletta Colombo, MD person default Philipp Harter, MD, PhD person default Alexandra Leary, MD, PhD Released: September 10, 2021

FAQ Audio Podcast/Podcast Pearls Summary Transcript

Listen to Nicoletta Colombo, MD; Philipp Harter, MD, PhD; and Alexandra Leary, MD, PhD, discuss patient cases from a live CCO webinar on the current paradigm and long-term benefits of PARPi therapy in the treatment of ovarian cancer.

Nicoletta Colombo, MD person default Philipp Harter, MD, PhD person default Alexandra Leary, MD, PhD Released: October 14, 2021

In this downloadable PDF transcript from a CCO podcast, Nicoletta Colombo, MD; Philipp Harter, MD, PhD; and Alexandra Leary, MD, PhD, discuss patient cases from a live CCO webinar focused on best management strategies in ovarian cancer treatment.

Nicoletta Colombo, MD person default Philipp Harter, MD, PhD person default Alexandra Leary, MD, PhD Released: October 19, 2021

ClinicalThought Commentary

Read this expert commentary to gain practical clinical insights on the current treatment landscape of PARP inhibitors and the role of biomarkers in ovarian cancer.

Nicoletta Colombo, MD Released: November 2, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings